{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:18:36Z","timestamp":1783477116418,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017694","name":"Guilin Scientific Research and Technology Development Plan","doi-asserted-by":"publisher","award":["20220129-2"],"award-info":[{"award-number":["20220129-2"]}],"id":[{"id":"10.13039\/501100017694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2020GXNSFFA325001"],"award-info":[{"award-number":["2020GXNSFFA325001"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160657"],"award-info":[{"award-number":["82160657"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560678"],"award-info":[{"award-number":["82560678"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioorg.2025.109274","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:30:15Z","timestamp":1763659815000},"page":"109274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of a novel diphenyl piperidinone-naphthoquinone STAT3 inhibitor as chemoimmunotherapeutic agent"],"prefix":"10.1016","volume":"167","author":[{"given":"Yi-Gui","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Chen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri-Zhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2025.109274_bb0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","article-title":"Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery","volume":"43","author":"Hu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109274_bb0010","doi-asserted-by":"crossref","unstructured":"K. Al Zaid Siddiquee, J. Turkson, STAT3 as a target for inducing apoptosis in solid and hematological tumors, Cell Res. 18(2) (2008) 254\u201367.","DOI":"10.1038\/cr.2008.18"},{"key":"10.1016\/j.bioorg.2025.109274_bb0015","doi-asserted-by":"crossref","unstructured":"H.Q. Wang, Q.W. Man, F.Y. Huo, X. Gao, H. Lin, S.R. Li, J. Wang, F.C. Su, L. Cai, Y. Shi, B. Liu, L.L. Bu, STAT3 pathway in cancers: Past, present, and future, MedComm (2020) 3(2) (2022) e124.","DOI":"10.1002\/mco2.124"},{"key":"10.1016\/j.bioorg.2025.109274_bb0020","doi-asserted-by":"crossref","first-page":"1110765","DOI":"10.3389\/fbioe.2023.1110765","article-title":"JAK\/STAT pathway: extracellular signals, diseases, immunity, and therapeutic regimens","volume":"11","author":"Hu","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bioorg.2025.109274_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115513","article-title":"Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing","volume":"167","author":"Dong","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109274_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in Cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109274_bb0035","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3390\/ijms19061591","article-title":"Structural biology of STAT3 and its implications for anticancer therapies development","volume":"19","author":"Sgrignani","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109274_bb0040","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1021\/acs.jmedchem.1c00629","article-title":"Recent update on development of small-molecule STAT3 inhibitors for Cancer therapy: from phosphorylation inhibition to protein degradation","volume":"64","author":"Dong","year":"2021","journal-title":"J. Med. Chem."},{"issue":"6689","key":"10.1016\/j.bioorg.2025.109274_bb0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/28101","article-title":"Three-dimensional structure of the Stat3beta homodimer bound to DNA","volume":"394","author":"Becker","year":"1998","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.bioorg.2025.109274_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27248768","article-title":"Role of STAT3 and NRF2 in Tumors: potential targets for antitumor therapy","volume":"27","author":"Tian","year":"2022","journal-title":"Molecules"},{"issue":"19","key":"10.1016\/j.bioorg.2025.109274_bb0055","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1042\/BCJ20160294","article-title":"Intermolecular disulfide bond influences unphosphorylated STAT3 dimerization and function","volume":"473","author":"Butturini","year":"2016","journal-title":"Biochem. J."},{"issue":"17","key":"10.1016\/j.bioorg.2025.109274_bb0060","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1074\/jbc.M111.323899","article-title":"Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA","volume":"287","author":"Timofeeva","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109274_bb0065","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1039\/c3cs35449k","article-title":"Progress towards the development of SH2 domain inhibitors","volume":"42","author":"Kraskouskaya","year":"2013","journal-title":"Chem. Soc. Rev."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109274_bb0070","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0092-8674(93)90404-E","article-title":"SH2 domains recognize specific phosphopeptide sequences","volume":"72","author":"Songyang","year":"1993","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109274_bb0075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/jmr.1047","article-title":"Characterization of molecular recognition of STAT3 SH2 domain inhibitors through molecular simulation","volume":"24","author":"Park","year":"2011","journal-title":"J. Mol. Recognit."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109274_bb0080","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/14756366.2020.1871336","article-title":"Design, synthesis, and in vitro evaluation of BP-1-102 analogs with modified hydrophobic fragments for STAT3 inhibition","volume":"36","author":"Oleksak","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109274_bb0085","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2174\/0929867329666220819093117","article-title":"Discovery of STAT3 inhibitors: recent advances and future perspectives","volume":"30","author":"Song","year":"2023","journal-title":"Curr. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109274_bb0090","doi-asserted-by":"crossref","first-page":"9623","DOI":"10.1073\/pnas.1121606109","article-title":"Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts","volume":"109","author":"Zhang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2025.109274_bb0095","doi-asserted-by":"crossref","unstructured":"A.M. Tsimberidou, D.J. Vining, S.P. Arora, S.d. Achaval, J. Larson, C. Cartwright, R. Avritscher, I. Alibhai, A.O. Kaseb, Phase 1 trial evaluating TTI-101, a first-in-class, orally bioavailable, small molecule, inhibitor of STAT3, in patients with advanced solid tumors, J. Clin. Oncol. 41(16_suppl) (2023) 3018\u20133018.","DOI":"10.1200\/JCO.2023.41.16_suppl.3018"},{"key":"10.1016\/j.bioorg.2025.109274_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106323","article-title":"Discovery of two biotin-PEG4-diarylidenyl piperidone prodrugs as potent antitumor agents with good efficacy, limited toxicity, and low resistance","volume":"131","author":"Liu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109274_bb0105","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00706-024-03220-5","article-title":"Synthesis and pharmacological evaluation of polyamine-diarylidenyl piperidone derivatives as potent antitumor agents","volume":"155","author":"Mao","year":"2024","journal-title":"Mon. Chem. - Chem. Mon."},{"issue":"23","key":"10.1016\/j.bioorg.2025.109274_bb0110","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1016\/j.bmc.2016.09.070","article-title":"4-Carbonyl-2,6-dibenzylidenecyclohexanone derivatives as small molecule inhibitors of STAT3 signaling pathway","volume":"24","author":"Ji","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109274_bb0115","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/1535-7163.MCT-09-1207","article-title":"Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts","volume":"9","author":"Selvendiran","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109274_bb0120","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1158\/0008-5472.CAN-13-2433","article-title":"HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer","volume":"74","author":"Rath","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109274_bb0125","doi-asserted-by":"crossref","first-page":"8378581","DOI":"10.1155\/2023\/8378581","article-title":"Curcumin Analog, HO-3867, induces both apoptosis and ferroptosis via multiple mechanisms in NSCLC cells with wild-type p53","volume":"2023","author":"Wu","year":"2023","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109274_bb0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12935-022-02732-6","article-title":"Cirsiliol regulates mitophagy in colon cancer cells via STAT3 signaling","volume":"22","author":"Jiang","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bioorg.2025.109274_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.archoralbio.2018.04.015","article-title":"Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma","volume":"92","author":"Liao","year":"2018","journal-title":"Arch. Oral Biol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109274_bb0140","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41419-022-05082-3","article-title":"Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3\/GPX4 signalling","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109274_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091280","article-title":"STAT3, a master regulator of anti-tumor immune response","volume":"11","author":"R\u00e9b\u00e9","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109274_bb0150","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.3390\/cancers15092424","article-title":"An Isoxazoloquinone derivative inhibits tumor growth by targeting STAT3 and triggering its ubiquitin-dependent degradation","volume":"15","author":"Xie","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.109274_bb0155","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bioorg.2018.10.044","article-title":"Design, synthesis and biological evaluation of fused naphthofuro[3,2-c] quinoline-6,7,12-triones and pyrano[3,2-c]quinoline-6,7,8,13-tetraones derivatives as ERK inhibitors with efficacy in BRAF-mutant melanoma","volume":"82","author":"Aly","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"16_suppl","key":"10.1016\/j.bioorg.2025.109274_bb0160","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1200\/jco.2005.23.16_suppl.3042","article-title":"Phase I trial of ARQ 501, an activated checkpoint therapy (ACT) agent, in patients with advanced solid tumors","volume":"23","author":"Shapiro","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"18_suppl","key":"10.1016\/j.bioorg.2025.109274_bb0165","doi-asserted-by":"crossref","first-page":"16509","DOI":"10.1200\/jco.2007.25.18_suppl.16509","article-title":"A phase II study of ARQ 501 in patients with advanced squamous cell carcinoma of the head and neck","volume":"25","author":"Kawecki","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.109274_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104208","article-title":"Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition","volume":"104","author":"Li","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109274_bb0175","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1021\/acs.jmedchem.9b01386","article-title":"Bifunctional naphthoquinone aromatic amide-oxime derivatives exert combined immunotherapeutic and antitumor effects through simultaneous targeting of Indoleamine-2,3-dioxygenase and signal transducer and activator of transcription 3","volume":"63","author":"Huang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109274_bb0180","article-title":"Structure, function, signaling pathways and clinical therapeutics: the translational potential of STAT3 as a target for cancer therapy","volume":"1879","author":"Dandan","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.109274_bb0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1476-4598-9-217","article-title":"A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells","volume":"9","author":"Lin","year":"2010","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109274_bb0190","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4161\/cbt.12.9.17713","article-title":"HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition","volume":"12","author":"Selvendiran","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109274_bb0195","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109274_bb0200","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1038\/s41598-022-08509-1","article-title":"Insight into redox regulation of apoptosis in cancer cells with multiparametric live-cell microscopy","volume":"12","author":"Shirmanova","year":"2022","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109274_bb0205","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.bmc.2019.03.002","article-title":"The design of 1,4-naphthoquinone derivatives and mechanisms underlying apoptosis induction through ROS-dependent MAPK\/Akt\/STAT3 pathways in human lung cancer cells","volume":"27","author":"Zhang","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109274_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115191","article-title":"Tumor killing by a dietary curcumin mono-carbonyl analog that works as a selective ROS generator via TrxR inhibition","volume":"250","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109274_bb0215","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109274_bb0220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2025.109274_bb0225","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109274_bb0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41420-024-01825-7","article-title":"Ferroptosis: emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation","volume":"10","author":"Jin","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bioorg.2025.109274_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102317","article-title":"Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer","volume":"52","author":"Ouyang","year":"2022","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109274_bb0240","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109274_bb0245","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1038\/s41467-020-19970-9","article-title":"Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death","volume":"11","author":"Hayashi","year":"2020","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109274_bb0250","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109274_bb0255","article-title":"STAT3 activation: a key factor in tumor immunoescape","volume":"2","author":"R\u00e9b\u00e9","year":"2013","journal-title":"Jakstat"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109274_bb0260","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/imr.13251","article-title":"Amplifying \u201ceat me signal\u201d by immunogenic cell death for potentiating cancer immunotherapy","volume":"321","author":"Xi","year":"2024","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109274_bb0265","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/ijms19020594","article-title":"Immunogenic apoptosis as a novel tool for anticancer vaccine development","volume":"19","author":"Montico","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109274_bb0270","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109274_bb0275","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41568-021-00344-2","article-title":"Autophagy in tumour immunity and therapy","volume":"21","author":"Xia","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109274_bb0280","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","article-title":"CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential","volume":"55","author":"Koh","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109274_bb0285","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1038\/s41467-019-12319-x","article-title":"Tissue-resident memory CD8(+) T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells","volume":"10","author":"Menares","year":"2019","journal-title":"Nat. Commun."},{"issue":"7086","key":"10.1016\/j.bioorg.2025.109274_bb0290","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04651","article-title":"Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction","volume":"440","author":"Castellino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.109274_bb0295","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1021\/acs.jmedchem.0c01936","article-title":"Dithiocarbazate-copper complexes for bioimaging and treatment of pancreatic Cancer","volume":"64","author":"Gou","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682501154X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682501154X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:59:10Z","timestamp":1777463950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682501154X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":59,"alternative-id":["S004520682501154X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109274","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel diphenyl piperidinone-naphthoquinone STAT3 inhibitor as chemoimmunotherapeutic agent","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109274"}}